Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy. - Wikidata - awgldk - TriplyDB

Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy.

Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy.

http://www.wikidata.org/entity/Q37367669

about

Natural Products in Epilepsy-the Present Situation and Perspectives for the Future.AGING OF THE SUBVENTRICULAR ZONE NEURAL STEM CELL NICHE.Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia.Omega-3 Fatty Acids and Primary and Secondary Prevention of Cardiovascular Disease.Role of ω-3 Fatty Acids in Cardiovascular Disease.Quantitative assessment of the degree of lipid unsaturation in intact Mortierella by Raman microspectroscopy.Effect of Omega-3 Polyunsaturated Fatty Acids Supplementation on Body Composition and Circulating Levels of Follistatin-Like 1 in Males With Coronary Artery Disease: A Randomized Double-Blind Clinical Trial.

P2860

Q33664290-FC4217F2-663F-49C9-96E8-E1C3EBD3ACDA Q35588124-9D3F151C-8F1A-4931-9C1E-9108F5693A7F Q35625968-8752D7DD-B21F-4644-993B-CB587AB5A73E Q38271779-A5F80F7A-3FC0-4318-8C37-05023167C167 Q38348619-8D919201-9D55-4F57-B772-A5D9C99BCFE8 Q46761715-93D427D4-ED50-4203-87B0-F82F63270D04 Q47103905-16C6995D-5222-4B93-82CD-3EE7CCCB4CA9

P2860

Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy.

http://www.wikidata.org/entity/Q37367669

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Omega-3 polyunsaturated fatty ...... secondary prevention strategy.

@en

Omega-3 polyunsaturated fatty ...... secondary prevention strategy.

@nl

type

label

Omega-3 polyunsaturated fatty ...... secondary prevention strategy.

@en

Omega-3 polyunsaturated fatty ...... secondary prevention strategy.

@nl

prefLabel

Omega-3 polyunsaturated fatty ...... secondary prevention strategy.

@en

Omega-3 polyunsaturated fatty ...... secondary prevention strategy.

@nl

P1433

Q37367669-58925FB3-3A4C-4B32-83C7-3E3EA78B8B68

P1476

Q37367669-819842F9-38E3-4CB4-86C2-2390DA144710

P2093

Q37367669-1F898531-EE4D-4F72-A3D6-D7A4EF3F461B

Q37367669-B941E51F-BF08-46FD-81A2-3542F5B2D95F

Q37367669-BE2F790F-014D-477A-BE0C-F7D3FAE10171

P2860

Q37367669-08169D67-5839-4568-8026-9276EAABE903

Q37367669-0AC19C1E-D227-46A4-958E-3435AA74A318

Q37367669-1154875E-8936-452E-9A41-45AE361B92B5

Q37367669-13FB6683-524D-4A6F-9183-0439B6854F7F

Q37367669-165EBA98-4696-4312-8644-2CAA874D6B72

Q37367669-1F1FC0C3-7458-490E-864F-DFDDC43FBAF3

Q37367669-20FF86A2-7149-4E17-A3CF-320E14726AFC

Q37367669-2C4E5F4F-C2B9-4A4F-9236-1A3C09101BF3

Q37367669-2CE365F5-7E97-41C1-86A3-B3AA6A700229

Q37367669-3132DED4-F32C-4FB3-83AB-7818A9EB07BB

P304

Q37367669-4AFF5E6E-6224-49B2-B148-6B99DB3C7AE4

P31

Q37367669-00DA26A6-9FB6-4695-8ADF-857A601886A8

Q37367669-7EA5A97B-62E7-4993-AA4A-475AD19791EA

P356

Q37367669-AFC13C8B-CA06-45F6-A411-CD33BAC5D327

P407

Q37367669-718D96EB-650F-4030-871F-2AFA9E862098

P478

Q37367669-1877A422-454A-4DD8-846D-3CADE0AF2727

P50

Q37367669-3C4A2276-EC7D-4B65-A5EB-C59C23483A70

P577

Q37367669-18BF5617-AA00-4ED0-A58D-6FE1827FC111

P698

Q37367669-89057BA3-0902-40F6-9C57-4AC923C4F905

P921

Q37367669-0D793717-8DFA-4B45-AE94-C6BBD13D7479

Q37367669-344DDFFB-0975-497D-BBEE-918FDC384A3B

Q37367669-40BDEF06-A3D5-4E70-B170-583B24E50AC4

Q37367669-49076FE7-804E-4692-9BAA-637258400000

P932

Q37367669-4128B16A-D2F4-470D-8371-0BF83F36B28E

P356

P1433

Vascular Health and Risk Management

P1476

Omega-3 polyunsaturated fatty ...... secondary prevention strategy.

@en

P2093

Elizabeth A Hughes

http://www.w3.org/2001/XMLSchema#string

Inessa Tracey

http://www.w3.org/2001/XMLSchema#string

Jeetesh V Patel

http://www.w3.org/2001/XMLSchema#string

P2860

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia

Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

The metabolic syndrome--a new worldwide definition

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

P304

801-810

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/VHRM.S4307

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Gregory Y. H. Lip

P577

2009-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19812692

http://www.w3.org/2001/XMLSchema#string

P921

preventive health services

P932

2754093

http://www.w3.org/2001/XMLSchema#string